James says he is sticking his neck out after seeing a significant increase in cases where dogs with diabetes are referred too late to save their sight.
He said: “If we are given the chance to assess a dog with diabetes as soon as cataracts develop then it is usually pretty straightforward to restore vision with a specialist operation.
“Often, diabetic dogs are referred to us too late because vets unwittingly delay referral while they enhance control of the diabetes.
“Unfortunately, this can mean it can become too late to perform sight-saving surgery and the dog may even have to have their eyes removed on welfare grounds.
“When cataract surgery wasn’t commonplace and as successful, maybe 20 years ago, there was more of a justification to delay surgery. But that isn’t necessary now with advances in veterinary care.
“It’s why it’s so important to improve education about this issue and raise more awareness of what can be done to both vets and dog owners alike.”
They say that dogs which lose sensation following damage to the spinal cord from a slipped disc have a prognosis for recovery of about 50%.
However, there is no reliable way of determining which dog will recover and failing that, owners must wait weeks to months to see if there are any signs of recovery, during which time dogs may need anaesthesia, surgery, and intensive nursing care.
The researchers say that the stiffness of an organ can be a marker of how damaged it is.
So, for the research, a new ultrasound machine equipped with an advanced piece of software (known as ‘shear wave elastography’) – will be used to measure the stiffness of a dog’s spinal cord during surgery.
The dog’s recovery to walking after surgery will then be monitored routinely.
The results will allow researchers to see if a relationship between spinal cord stiffness at time of surgery and recovery exists.
If successful, this would help them provide a more accurate prognosis for dogs with spinal cord injury in the future.
If you have a case suitable for this study, CVS says they will receive a gold standard treatment for spinal cord injury, which will include spinal surgery.
They will also have an ultrasound of the spinal cord performed during surgery, a procedure taking approximately 15 minutes.
Contact referrals@highcroftvet.co.uk or nicolas.granger@bristolvetspecialists.co.uk.
BVS Neurology study from CVS (UK) Ltd on Vimeo.
Fabtek Solutions has announced the launch of Meditek, an activated carbon wound dressing which has been impregnated with silver to enhance its antibacterial qualities.
Joy Coutts from Fabtek Solutions said: "Meditek uses Zorflex which is a 100% pure activated carbon fibre. It has a huge surface area due to its microporous structure, and a permanent electrostatic charge that attracts bacteria towards it, where they are immobilised and retained. When removed from the substrate, the bacteria die, but the microscopic particulates of metallic silver accelerate the bacteria kill.
"Better still, Meditek carries no risk phases as it's non toxic and non invasive."
Joy added: "We are commercial members of the Vet Wound Library, an initiative designed to help promote modern wound care to veterinary professionals, it also means members can try our dressings for free."
According to Fabtek, Meditek has been tried and tested by vets and produced excellent results. The company's website also features some case studies which show the wound before and after the use of Meditek.
Dressings are available in 10cm x 10cm, and 15cm x 25cm sizes, which can be cut to fit. Prices start from £35 for a box of five.
For more information, see http://www.fabteksolutions.com/, email admin@fabteksolutions.com or call 07794094011.
The research project, which is being carried out by RVC student Collette Taylor for her PhD, is looking at the development of novel diagnostic targets to establish the specific leptospira implicated in canine clinical cases.
Collette said: "Existing leptospirosis diagnostics have a number of limitations. MAT serological testing may provide information that can be supportive of a serogroup diagnosis but may also provide false positives due to previous vaccination or indeed be confounded by cross-reactivity. It can also be difficult to interpret serology in the absence of paired samples.
"PCR tests are sensitive, usually specific, but are dependent on timing of sampling and do not tell you which serovar is concerned.
"My research is focused on offering more specialised diagnostic tests which can differentiate antibodies associated with infection from those due to vaccination. Extending this theme, our group is interested in further typing of samples where the Leptospiral DNA is identified using Multi-locus sequence typing (MLST). I am now at the stage of validation and we are able to offer additional testing of serum or blood test samples from confirmed clinical cases."
If you'd like to send in a sample for further tests, you will need to complete a questionnaire, and samples must be from confirmed cases of leptospirosis that have already undergone leptospirosis diagnostics from another laboratory.
John Helps, Senior Technical Manager, Companion Animals, MSD Animal Health said: "As a 3rd year PhD student Collette has two main areas of study. The first is looking at the risk factors of leptospirosis including ecological niche modelling for specific serogroups in different regions across the country. The second part is the development of new specialised diagnostic tests that can provide better targeted serological approaches to diagnosis of this disease."
"As a potentially serious zoonosis, leptospirosis is an important differential diagnosis for a variety of canine disease presentations. These include not only acute renal or hepatic disease; it should also be on the differential list in conditions such as uveitis and retinal bleeding, acute respiratory distress, and haemorrhagic gastoenteritis when parvovirus is excluded.
"Collette's highly valuable research expands understanding of the epidemiology of canine leptospirosis within the UK. Veterinary practices that take advantage of this scheme will gain a better understanding of locally relevant disease data which is likely to better inform the approach to dog vaccination."
For further information contact Collette Taylor at ctaylor18@rvc.ac.uk.
The event is merging with the new northern VETcpd Congress to give attendees a broader range of CPD subjects.
In the wound management streams, which are for both nurses and vets, Shelly Jefferies (pictured right) will run a series of workshops on: ‘Wound preparation for optimum healing’, ‘Wound dressing selection’ and ‘Building a better bandage’.
On the first day of the lecture programme, Samantha Bell will be looking at various different aspects and considerations for wound management through all stages, from initial presentation and assessment of the traumatic wound patient, including lavage and debridement techniques, to selection of dressings for open wound management, to surgical closure.
Other speakers in the wound management stream will cover topics such as acute wound management in rabbits and other exotic species, coping with eye problems and what to do and what not to do after oral surgery to allow healing.
Alongside the wound management programme will be two streams for veterinary surgeons – open to nurses as well – with Dr David Williams (ophthalmology), Dr Bob Partridge (dentistry), Dr Molly Varga (rabbits and exotics), Dr Fergus Allerton (antibiotics and immune-mediated diseases), Professor John Innes (orthopaedics), Professor Jon Hall (small animal surgery), Dr Joanne Harris (cardiology), Dr Alison Hayes (oncology), Dr Samantha Lane small animal surgery), Dr Anita Patel (dermatology) and Angie Lloyd-Jones (ultrasound).
On day two, David Williams will conduct an interactive session on ethics in which he will present a series of cases and ask the audience to discuss what they would do in each.
There will also be a series of workshops on ultrasound, covering basic system controls and image optimisation, abdominal ultrasound assessment techniques, and other aspects.
Lastly, there will be a stream specifically for equine practitioners featuring Professor Michael Schramme of the University of Lyon, Dr Alison Talbot of the University of Liverpool, Dr Lesley Young from Newmarket, Dr Gemma Pearson from Edinburgh, David Green from the VDS and Philip Cramo of Hambleton Equine Clinic.
Accommodation is available in the Hilton Garden Inn on-site at £105 per night or £125 per night for double occupancy. This rate is available by emailing HGIreservations@doncaster-racecourse.co.uk, quoting VETcpd.
Early bird two day passes cost £285+VAT for veterinary surgeons and £195+VAT for veterinary nurses, with one day tickets also available.
www.vetcpdcongress.co.uk.
Krka’s Farm Key Account Manager Charlotte Read said: “BRD remains a priority issue on farm and advising farmers on the management of BRD risks, and treatment options when needed, is a key task for farm vets.
"Flovuxin’s combined formulation is a high efficacy BRD treatment acting within six hours1, to improve treatment outcomes.”
Reference
Dechra says Equisolon is the only registered oral prednisolone powder that alleviates the inflammation and clinical parameters associated with severe equine asthma, previously known as recurrent airway obstruction (RAO).
Equisolon Jar contains 180g of powder and comes with a measuring spoon.
One scoop is enough to treat 150kg bodyweight at a dose of 1mg/kg and therefore one jar can treat a 600kg horse for 10 days.
Equisolon was previously available as a box of 10 x 9g pre-measured sachets with one sachet sufficient to treat a 300kg horse and a box contained enough sachets to treat a 600g horse for five days.
Alana McGlade, national sales manager at Dechra said: “The addition of Equisolon Jar to the Equisolon range provides vets with the flexibility to choose between a jar featuring a convenient measuring spoon and a box of easy to dose pre-measured sachets
www.dechra.co.uk/products/horse/prescription
The Prime Minister's website has received a petition for a new law making it compulsory to microchip pets in the UK.
If you wish to support this petition, please click here and add your name: http://petitions.number10.gov.uk/MicrochipPets/
The full petition reads:
"I am a responsible pet owner and have both my parrots and dog microchipped. I genuinely believe that all pets (where possible) should be microchipped.
I feel that it should be mandatory and is part of being a responsible pet owner. This should act as a "licence". I strongly beleive that this course of action will protect many discarded, stolen and mistreated pets every year as there will be no escape for the owners as the pet can be traced back to them.
I appreciated that due to size and temperament some pets may not be able to be microchipped, but certainly dogs, cats, horses, valuable / larger birds, rabbits etc should be.
I hope you agree that £30 for a microchip is good value, if owners cannot afford this then they shouldnt be considering a pet in the first place.
Please can you give this idea serious consideration as I feel we must do something to protect the pets that do not have a voice in our society."
The original survey was sent last year to more than 5,000 UK-registered veterinary surgeons and veterinary nurses who gained their qualification from a non-UK EU institution, with a response rate of around 55%.
This year the Institute for Employment Studies (IES), on behalf of the RCVS, contacted over 6,000 veterinary surgeons and almost 50 veterinary nurses – including those previously surveyed as well as EU registrants who have joined since the last survey – who trained in non-UK EU countries to seek their views on the implications of Brexit for European veterinary professionals.
Chris Tufnell, RCVS Senior Vice-President and Chair of the College’s Brexit Taskforce, said: "The aim of this survey is to gain a greater understanding of the views and expectations of our EU colleagues now that certain elements of the UK’s withdrawal process from the European Union, as well as the timing, have become clearer. The survey will also be looking for the views of colleagues on how the College has addressed the challenges of Brexit so far.
"It is particularly important that those who responded to last year’s survey do so this year because the aim is to get a sense of how their views and plans are shifting as the Brexit process moves forward."
As with last year’s survey, the views collated through the consultation will help the College understand the immediate and longer-term impact of the UK’s exit from the EU, gather evidence that could be used to make a case for special treatment of veterinary professionals with regard to future immigration policies and allow the College to provide informed advice to European veterinary professionals as they make decisions about their future careers.
Dr Tufnell added: "I would strongly encourage EU veterinary professionals to respond to this survey, even if they didn’t do so last year, as their views really do matter to us and really do have an impact on our Brexit policies and the views we put forward to the government in these critical times."
The deadline for sending responses to the IES is Wednesday 18 July 2018 and all data will be managed and analysed by IES, an independent not-for-profit research institute, on a confidential basis with no individual responses being seen by the RCVS.
The College says it intends to conduct a third survey when the terms of the UK’s withdrawal from the EU, and the impact of this on non-UK EU nationals, are better defined.
Vetoquinol UK has launched Dolpac®, its new wormer for dogs.
Dolpac® is a broad spectrum anthelmintic for dogs containing pyrantel, oxantel and praziquantel. Individually these ingredients are effective against individual worm species and the combination of all three provides specific activities against the most common roundworm and tapeworm species.
According to the company, clinical studies carried out in accordance with internationally recognised guidelines have shown that Dolpac® provides an excellent ability to reduce parasitic infection.
“Dolpac® offers vets and their clients an easy to use worming alternative at an affordable price,” explains Mark Leddy, Vetoquinol’s Marketing Department Manager. “Our aim is to help to increase the number of dog owners worming their pets at the correct frequency, which will not only protect their dogs, but their children as well. We have introduced a number of features to help achieve this objective, there are three tablet sizes to cover all weight ranges and the tablets are flavoured and easy to give, and there are dispensing envelopes in every pack. We also provide a dosing wall chart and a client worming guide.”
For more information, contact your Vetoquinol representative or visit the Dolpac website, http://www.dolpac.co.uk/, which offers information for both vets and clients.
Ceva Animal Health has launched PRID Delta, described as an improved intra-vaginal progesterone device for the synchronisation of oestrus in cycling and non-cycling cattle.
The company says it has used its 35 years of expertise in cattle fertility to develop PRID Delta, and that trials have demonstrated that the new device provides optimal progesterone release, preserved efficacy and high retention rates.
Ceva claims the special triangular shape and bi-material fabric of PRID Delta ensures maximum contact with vaginal mucosa to release optimal levels of progesterone at insertion and during treatment. The new PRID Delta continues to give a bigger progesterone peak after insertion as with the original PRID.
According to the company, clinical and field trials observing oestrus occurrence and fertility at fixed time artificial insemination have shown a preserved efficacy for PRID Delta. PRID Delta is licensed for oestrus synchronisation in both cycling and non cycling cows. It is licensed for fixed time AI. Trials have also confirmed that PRID Delta is quick and easy to insert, is well tolerated and has a retention rate of over 97%.
Ceva has recently introduced a new website www.reprology.com/ for technical advice on the best solutions for the management of cattle reproduction. For further information contact your Ceva sales representative or Ceva Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, telephone 01494 781510 or visit the website at www.ceva.uk.com/
Loseley, the ice-cream maker, has announced that it has developed a new way of making flavoured ice-cream by adapting the diet fed to its cows.
The first variety to be made using the new technique is 'Eton Mess', for which the company's herd is being fed a diet of strawberries and meringues.
Loseley says its cattle - which are housed at the Beechdean Dairies farm in Buckinghamshire - have already been feeding on the ingredients found in the much loved pudding for over a year, to ensure their milk supply is infused with the strawberry and meringue flavours. Apparently, huge amounts of strawberries are having to be air-freighted into the UK in order to ensure an uninterrupted supply through the seasons.Andrew Howard Managing Director of Beechdean Dairies said: "We have been perfecting the quantities in the cattle feed for over 18 months to perfect the Eton Mess flavour. The cows need to be fed just the right quantities of meringues, strawberries, fat and hay to make the perfect Eton Mess ice cream. We believe ice cream should be great quality, tasty and interesting. Our products will always deliver against these criteria."Vince Bamford, Fast Moving Consumer Goods Editor at The Grocer, the UK's leading grocery trade magazine said: "Loseley's flavour development process is cutting edge - I have tasted the product and it is delicious. It is an exciting innovation for the ice cream category."
Andrew Groom has been appointed as the new Country Manager for Kruuse UK Ltd based near York, following the promotion of Lars Lund and his relocation back to Kruuse A/S in Denmark. Andrew takes up this new position to head up the UK sales and marketing team and to help implement the expansion programme within the veterinary and pet markets that Kruuse has planned for 2008.
Having studied agriculture and gaining a DHM, Andrew managed large farming operations, as well as being a contributing writer for the agricultural journal “Farmers Weekly”. He then continued his education by studying commercial management at Circencester College from where he went to United Milk as a Farm Liaison manager and commercial manager. His career progressed when in 2004, he joined Arnolds Veterinary Products as sales manager.
“I have known about Kruuse and its wide range of products for many years and have always admired the company’s vision in bringing innovative products onto the market for both the large and small animal sectors, including high quality pet toys and accessories,” said Andrew. “So when an opportunity arose to work for Kruuse in the UK, I did not need much persuading to apply for the job.”
“Andrew’s vast experience in both large and small animal industries will prove a real asset in all of the important market areas in which Kruuse operates,” commented Hans Alsted, Kruuse A/S Export Director.
Novartis Animal Health has launched a chewable formulation of Milbemax wormer, for dogs.
According to the company, clinical studies have shown that the chicken-flavoured formulation and chewy texture of Milbemax Chewable Tablets is highly palatable, with more than 94% of dogs showing spontaneous acceptance from hand. Novartis says this should help make worming simpler and improve compliance, something which is particularly important given market research which shows that difficulties in administering medications often leads to missed treatments.
Containing milbemycin oxime and praziquantel, the new tablets deliver the same broad spectrum efficacy as existing Milbemax formulations, effective for the treatment of roundworm, hookworm, whipworm, lungworm and tapeworm, and for the prevention of heartworm.
Folkert Kamphuis, Chief Operating Officer at Novartis Animal Health said: "The new EASYCHEW™ formulation represents Novartis Animal Health's latest innovation. It will make worming a treat whilst providing tried-and-trusted Milbemax efficacy. With Milbemax chewable tablets we give pet owners a wormer that is easy to administer and veterinarians the trusted efficacy of Milbemax."
Milbemax Chewable Tablets are available for both dogs and puppies, in four and forty-eight tablet packs.
BCF has announced the launch of the Medison Sonovet R3 portable ultrasound scanner.
BCF says the R3 is the next evolution of the Pico from Medison which is ideal for both equine and small animal vets. It is now more compact with a robust design with enhanced image quality and improved frame rate, and even at a lower price.
Graham Howe, Partner at Stow Veterinary Surgeons in Gloucestershire has one of the new machines. He said: "We chose the Medison R3 for several reasons. The R3 is an excellent quality machine at the right price and provides excellent value for money. We wanted Doppler and the R3 provides this without breaking the bank.
"The scanner has increased our diagnostic capabilities and enabled us to diagnose increasingly subtle lesions in small animal anatomy.
"We also knew from previous experience with previous with an ultrasound scanner and digital X-ray machine that we could rely on BCF for support."
For more information visit http://www.bcftechnology.com/, or call +44 (0)1506 460023 to arrange a demonstration.
The course covers wound management, making decisions on dressings, drain management, how to complete biopsies and fine needle samples, how to complete a number of suture patterns and how to remove cutaneous masses and complete other surgeries under Schedule 3 legislation.
The course includes eight hours of practical skills training on cadavers as well as 2 hours online training, covering suture selection and legislation.
On completion of the course, CVS nurses are able to recognise what nurses can complete under Schedule 3 legislation, identify the correct dressing for each stage of wound healing, identify the equipment and correct technique for a range of biopsies, complete a number of different suture patterns, and remove cutaneous masses and complete other surgeries under Schedule 3 legislation.
Each nurse has a skills checklist to inform their ongoing training needs and is encouraged to have regular, informal meetings with a local mentor – who is able to support their learning.
The next Surgical Schedule 3 Course is scheduled for 21st March 2024.
Karen Learmonth, LED Nursing Lead at CVS said: “I am excited about the opportunity that Surgical Schedule 3 provides for nurses within CVS to further their skills and knowledge.
"Advocating nurses’ involvement in Schedule 3 procedures supports improved patient care and provides nurses with rewarding careers.
“It’s fantastic to see so many nurses completing the course to date and we’ll further develop nurse utilisation in 2024 where we’ll rollout both ultrasound and lab skills training.
"We hope this will encourage nurses to utilise all aspects of their role in line with Schedule 3 guidelines.”
Fran Wood, an RVN at Albavet - Rogers, Brock & Barker said: “I have been loving doing surgery and felt the course was the best CPD I have ever been on!
"It has given me the confidence to complete stitch ups, tail amputations and many other procedures.”
One of the critical factors in allowing vet nurses to use all their skills is having vets who are comfortable delegating.
To that end, CVS has vets who have pledged to support nurses to achieve this work.
The group has also published guidelines for its vets to provide clarity around effective delegation under Schedule 3.
Pet insurer esure has released the results of a survey of vets bills, carried out amongst 3000 pet owners.
Whilst the intent behind surveys like these may be laudable (i.e. to encourage more pet owners to insure their pets), they do the profession no favours, emphasising the high perceived costs of veterinary care rather than the good value that it generally represents.
This survey highlighted that:
esure's research showed that English Setters are the mostly costly breed of dog, forcing their owners to shell out £6,955 on vet bills, including injections, surgery and emergency treatments, in a lifetime.
Despite the potential for big bills, just a third (31 per cent) of pet owners have pet insurance and almost a quarter of those with cover admitted they were considering cancelling it to save money during the current credit crunch.
According to esure, many dog owners may be choosing to cancel or not even buy pet insurance because they are significantly underestimating the cost of treating common ailments and injuries. 29 per cent of pet owners surveyed think that the average vet bill for a dog with diabetes would be under £200, when it is actually £1146 including ongoing treatment*. To repair a dog's broken leg, 11 per cent of pet owners think that the average vet bill would be less than £100. It is actually more than five times that amount at £560*.
Mike Pickard, Head of esure pet insurance said: "Sickness, injury and long-term illness can affect any breed of dog, at any time, which is why it's crucial for pet owners to have insurance or ample savings to cover an unexpected vet bill of any size. With many pet owners underestimating the cost of treatment for common ailments, a hefty vet bill may stretch household finances to the limit - especially in the current credit crunch. Pet owners should plan ahead for all eventualities when it comes to their dog's health."
VET BILLS FOR THE TOP 10 MOST POORLY DOG BREEDS:
* Based on all claims received by pet insurance specialist, Thornside in 2008. http://www.bdml.co.uk/about-thornside.html
Medivet senior partner Adi Nell says the profession needs to consider new business models to encourage more vets into ownership, as well as fresh approaches to supporting the role.
Responding to issues and recommendations highlighted in the latest VetFutures report, such as the number of female practice owners and a perceived lack of business skills in the profession, Adi said practices need to be flexible when it comes to attracting new vets or owners.
"Client expectations have changed drastically in the past 15 years, but so have the desires of potential practice owners. The world of clinical practice is changing at a rate we’ve never seen before. Owning a practice, along with the other increasing demands on our limited time and energy, is becoming more of a challenge too. This is evident with the growth of business support and development services, indicating an increased demand for that support.
"New practice owners aren’t like previous generations. Although traditional models of ownership are changing gradually, we also need different models of working, such as flexible hours, and different methods of support are needed."
One of the trends noted in the 2014 VetFutures report was how, despite dominating the profession in terms of overall numbers, women are still less likely to be a sole principal, director or partner.
Medivet claims an excellent track record here, with a near 50/50 split of male and female branch owners/partners.
Adi added: "We’re very happy to have so many women as business partners with us. The combination of clinical freedom, business support and a real feeling of teamwork and care for each other are some of the features that enable our partnership model to work so well. The scope for clinical and business development is huge, and we do our very best to look after all our people as they grow.
"However, there are still far too many bright, talented and highly trained vets leaving the profession after too short a time. Why do we turn these diamonds into coal? We need to understand what’s driving this and how we can adapt. The VetFutures report starts to offer some of the answers – and has uncovered even more questions!"
The VetFutures report also found aspirations of practice ownership or partnership dropped from 45% among students to 25% once vets start work. Adi says that offering opportunities for vets to expand into other areas of expertise is key to reducing the decline in appetite for practice ownership. He said: "I started out offering dermatology referral services to various Medivet branches before becoming a branch partner myself. I’m now in charge of a Medivet region of 16 practices as well as being involved in strategy, marketing, HR and operations, which I absolutely love, but never predicted I would do.
"I believe fewer and fewer vets see themselves doing the same job in clinical practice for their entire careers. That includes not wanting to be an employee for life, but also not wanting to have all the responsibility and burden of individual practice ownership. A big group like Medivet allows them to find the niche they enjoy and to develop the skills they value, to the benefit of their own careers, their business success, their client care and their patients’ health."
Phovia is a two-part FLE system consisting of a chromophore gel that is applied to the affected skin and a blue light LED lamp.
When used together they produce light of varying wavelengths that penetrates the skin to different depths, which Vetoquinol says helps to control bacteria and reduce inflammation on the surface of the skin and stimulates regeneration in the epidermal and dermal layers.
The unit is portable, and applications take four minutes once a week.
After diagnosis and subsequent recommendation by a veterinary surgeon, any trained member of the clinical team can use Phovia.
For the study, which was led by Dr. Andrea Marchegiani, nine female dogs that had undergone unilateral or bilateral mastectomy for mammary neoplasia had half their wounds treated with FLE, whilst the other half served as the control and received no FLE.
To assess the potential benefits of FLE in reducing infection risk, swabs were taken for culture and sensitivity three, five and seven days after surgery.
The swabs from all FLE-managed wound portions showed no bacterial growth, in contrast to the control wounds, in which three dogs had positive culture results.
Andrea said: “For many reasons healing of surgical wounds can become challenging, especially after removal of mammary gland lumps.
"Veterinary clinicians have to face the three-fold challenge of meeting owner expectations of prompt and trouble-free wound healing, recognising those wounds in which healing may be prolonged or impaired and also following the principles of antibiotic stewardship.”
The study concluded that the research underscores the value of Phovia as a significant adjunct to conventional postoperative care in veterinary medicine, offering the dual benefits of reducing potential infection risks and lessening the home care burden for pet owners.
FLE’s application could potentially replace certain topical treatments and improve overall compliance by simplifying the administration of home therapies, thereby relieving pet owners of some responsibilities associated with postoperative care.
https://www.mdpi.com/2076-2615/14/8/1250
The AHT has secured an award of £580,000 from the Wellcome Trust to fund the development of a new diagnostic test for Strangles which takes only 30 minutes.
It's been achieved in part by 'Breaking the Strangles Hold' - a two-year fundraising campaign run by the Animal Health Trust (AHT) and The British Horse Society (BHS),
Money donated from the general public, along with funding from The Horse Trust, has already allowed scientists at the AHT to develop a diagnostic blood test which gives results in 24 hours. The blood test was launched in February 2008 and since then more than 6,700 samples have been tested.
HRH The Princess Royal, who launched the 'Breaking the Strangles Hold' campaign, said: "As an owner who has seen my own horse's affected by this terrible disease, it's wonderful to see such progress being made in a relatively short time.
"The screening test enables owners to know within 24 hours if any of their horses have been exposed to this bacterium. Previously available tests would have taken three to four days. The test is making a real difference in welfare and economic terms for all those involved in the equine industry. It truly is groundbreaking."
The success of this diagnostic work, along with other AHT research, has attracted further funding for the project from the Wellcome Trust in the form of a £580,000 Translation Award.
Professor Andrew Waller, Head of Bacteriology at the AHT, said: "The main problem with Strangles is the time taken to diagnose it. The current blood test is a big step forward, but the culture and DNA tests, which are often used in the initial stages of an outbreak can take a couple of days to get results."
The Translation Award means the AHT can reduce the time taken to perform its DNA diagnostic test and ultimately produce a point-of-care test that vets can use on site to get a diagnosis in 30 minutes. Earlier diagnosis will allow owners to isolate horses sooner and minimise the spread of infection. It will further reduce welfare problems for horses and the cost to their owners.
The AHT and Atlas Genetics will design and validate the point-of-care diagnostic test over the next two years. It is hoped that the test could be mass produced and widely available by 2012.
Professor Waller added: "This technology will be fantastic. It will be hugely beneficial for other diseases too, of both veterinary and clinical importance. Without the money raised through the 'Breaking the Strangles Hold' campaign, we wouldn't have made as much progress. On behalf of horses and horse owners worldwide, I'd like to thank everyone who has donated."
The 'Breaking the Strangles Hold' campaign reached its fundraising target of £250,000 in just two years, demonstrating how important to horse owners it is to get to grips with this terrible disease.
For more information, see: http://www.strangles.org
Awarded by The University of Central Lancashire (UCLan), the programme starts in March 2024.
The programme combines practical training with reflective learning and enables veterinary surgeons to achieve their PGCert within 12 months.
Vet and PGCert Programme Manager, Alison Malone, said: "This course came about as a result of listening to what vets in practice want, and many wanted a focused soft tissue surgery curriculum without the orthopaedic element amid concerns that their practices don’t have the case load to benefit from the advanced learning.
"The Soft Tissue Surgery PGCert provides delegates with hands-on experience for the cases they will be seeing frequently, making a dramatic impact to their daily work life”.
The Soft Tissue Surgery PGCert comprises three modules: Essentials of Small Animal Soft Tissue Surgery, Small Animal Abdominal, Perineal and Urogenital Surgery, and Small Animal Head, Neck and Thoracic Surgery.
Each module begins with three days of practical sessions at CPD Solutions Training Centre in Warwickshire provided by tutors Lynda Rutherford, Faye Swinbourne, Will Robinson, Lara Dempsey, Elinor Field and Lee Meakin.
There are 20 spaces on the PgCert in Small Animal Soft Tissue Surgery starting next March.
The course costs: £10,947 + VAT, plus you'll also need to register with the University of Central Lancashire, which costs £2630 (No VAT) for UK students.
www.pgcert.com
The College says its Veterinary Graduate Development Programme (VetGDP), which will be replacing the Professional Development Phase (PDP), has been developed in response to detailed feedback from the profession during the 2018-19 Graduate Outcomes consultation, which looked at how graduates could be better supported during their transition into working life.
One of the main changes will be the introduction of VetGDP Advisers for all new graduates enrolling onto the programme, to provide one-to-one support and advice to help build the confidence and skillsets of new vets.
Practices wanting to employ veterinary graduates from summer 2021 will need to have at least one trained VetGPD Adviser in the workplace. This will involve a short, free online training course and will contribute to their practice being recognised as an RCVS-Approved Graduate Development Practice (for non-clinical settings they will be called RCVS-Approved Graduate Development Employers).
Dr Sue Paterson, Chair of the RCVS Education Committee, said: “When we conducted the Graduate Outcomes consultation, one very clear message that came across from graduates was that they felt there was a need for more bespoke, hands-on and one-to-one guidance from a designated person in their practice.
"The role of VetGDP Adviser is to help graduates identify areas of strength and areas for improvement, to closely monitor and provide feedback on their performance, and to support them in finding their feet as a newly-qualified professional. We hope all this will help increase their confidence and competence and, crucially, ensure we are doing more to retain our young vets in the profession and that this investment in our young talent will, in turn, benefit practices and the profession at large.
“Ahead of the introduction of VetGDP next summer, we want to give the profession advance notice of the coming changes and ask members of the profession who have been on the UK-practising Register for at least three years, and who are passionate about supporting the next generation of vets, to consider becoming VetGDP Advisers.
"We will be introducing free formal online training for VetGDP Advisers from April 2021 but we are asking vets to register their interest as soon as possible so they can find out more about what the role will entail and how it will support new graduates.”
The training will comprise approximately 20 hours of e-learning using a mixture of different methods including case studies, reflective exercises and recorded presentations and will cover topics such as giving effective feedback to support, encourage and motivate; coaching techniques; the provision of guided reflection; goal-setting; reviewing progress; and mentoring.
The training is being provided online by the RCVS and can be undertaken flexibly at any time. It can also count towards the annual continuing professional development (CPD) requirement.
Once an individual has completed the training, and committed to providing the equivalent of at least one hour of support each week per graduate employed, they will receive VetGDP Adviser status. The role will include observing their graduate’s practice and providing feedback and guidance where appropriate.
Veterinary practices with at least one employed VetGDP Adviser will also be formally recognised as an RCVS-Approved Graduate Development Practice, which will indicate that they are able to employ new graduate veterinary surgeons and have the necessary support and development structures in place.
Dr Linda Prescott-Clements, RCVS Director of Education, added: “Developing VetGDP has been a significant step forward in supporting graduates to establish fulfilling veterinary careers. I would like to thank all those members of the Graduate Outcomes Working Group, the Education Committee and RCVS Council who have been involved in putting together the programme, as well as all those veterinary professionals and students whose feedback was crucial in shaping the direction of travel.
“The programme recognises that the profession would like to see a range of ways to support graduates in the workplace, involving a balance between professional and clinical skills. The need was for a programme to reflect their everyday work and professional development in the workplace, with a much greater focus on structured and meaningful support. This support is crucial in developing them beyond their Day-One Competences into becoming confident, capable and independent veterinary professionals.
“As all new vet graduates from summer 2021 will be required to undertake the VetGDP, practices and other workplaces taking on new graduates will need to have at least one VetGDP Adviser and RCVS-Approved Graduate Development Practice status. The online training is not onerous, it is free of charge and takes approximately 20 hours; furthermore, it can be counted towards CPD hourly targets for the year. We envisage that the VetGDP Adviser role will be highly rewarding, with the personal satisfaction of knowing you’re helping to shape and support the next generation of vets.
“Please do make sure to take a look at the full range of resources that we have produced about VetGDP and familiarise yourself with the coming changes.”
To aid understanding of the VetGDP, the RCVS has produced a number of resources, including FAQs, further information for those who are interested in becoming VetGDP Advisers, and information for students, which can be found at: www.rcvs.org.uk/lifelong-learning/vetgdp
From early 2021, the RCVS will be holding online video seminars with final-year veterinary students from all eight UK veterinary schools to discuss VetGDP in further detail.
Anyone with further questions about VetGDP should contact the RCVS Education Department on vetgdp@rcvs.org.uk
The company is encouraging owners to post a simple 'thank you' on Facebook with the hashtag #thankuvets.
Boehringer has also produced a thank you video, depicting a day in the life of an equine vet during these tough times.
Warren Ball, Equine Brand Manager at Boehringer Ingelheim Animal Health, said: “This year has been a year like no other, but equine vets throughout the country have carried on regardless of the challenges they face and are deserving of a huge thanks from all who need them.”
"Our ‘Thank You Vets’ initiative will show how appreciated each and every vet is by bringing together owners, trainers and others in the equine community."
To watch the video and see the thank you messages from owners, visit: https://www.facebook.com/equitopmyoplast/posts/2188633904615007
What a lovely initiative. Makes a change from the usual griping on Facebook.
The Disciplinary Committee of the RCVS has approved an application for restoration to the Register from an Oxfordshire veterinary surgeon who had been struck off for false certification.
In November 2007, the Committee decided that Mr John Williams, of the Avonvale Veterinary Practice in Ratley, near Banbury, should have his name removed from the RCVS Register, having found him guilty of disgraceful professional conduct. Mr Williams had admitted signing export health certificates for three horses in October 2006 to state that they had received negative test results for the contagious equine metritis organism, before these results were actually available.
At the time, Mr Williams was working in his capacity as an Official Veterinarian (OV) for DEFRA and he had previously been suspended from his official duties on three separate occasions, on the basis of export certification irregularities. It was accepted that Mr Williams had not been dishonest, but his approach to certification was described by the Disciplinary Committee as "either irresponsible or cavalier or both".
In December 2007, Mr Williams appealed against this decision to the Privy Council but this was dismissed at a Hearing the following June. He was then removed from the Register in July 2008.
When the Committee met on Monday to consider Mr Williams' application, they heard oral and written supporting evidence from veterinary surgeons and equine clients, and oral evidence from Mr Williams himself. The Committee was satisfied that Mr Williams accepted its previous findings and fully understood their seriousness. He described his removal from the Register as a "salutary experience" which had been highly significant for him and his family, both financially and emotionally.
The Committee stated: "Although the decision of the Committee to remove [Mr Williams] from the Register sent a clear message to the profession of the importance of certification, it should be emphasised that his removal was the consequence of his actions in signing certificates which he could not verify. This followed three previous occasions on which he had similarly signed certificates when he should not have done so."
However, the Committee was satisfied that Mr Williams would not in future sign certificates when he should not do so, even under severe client pressure. It was impressed with the continuing professional development he had undertaken whilst off the Register and noted that no questions had been raised over his conduct during this time.
It concluded that Mr Williams fully understood the importance of accurate certification and that restoring his name to the Register therefore posed no risk to animal welfare. Neither the public nor the profession would benefit from Mr Williams staying off the Register for a further period.
Alison Bruce, Disciplinary Committee Chairman, said: "We would like to make it clear that we always find it distressing to remove clinically competent veterinary surgeons from the Register because of an irresponsible and cavalier attitude towards certification. This would not be necessary if veterinary surgeons were to follow the Twelve Principles of Certification annexed to the RCVS Guide to Professional Conduct."
The Committee then approved Mr Williams' application and directed that his name should be restored to the Register.
Boehringer Ingelheim Vetmedica has announced that it will be launching Bovela, a new viral diarrhoea (BVD) vaccine, to farmers during April 2015.
Allan Henderson from Boehringer said: "BVD remains the most common viral disease affecting cattle throughout Europe, despite vaccines being available for over 15 years. We asked farmers why this was the case and, without exception, they remarked that current vaccine protocols are unwieldy, requiring precise timings making them hard to follow.
"Bovela is a unique one-shot vaccine that can be used in cattle from three months of age and also whether pregnant or not. Other, currently available vaccines require a two-dose primary course with boosters annually or even every six months thereafter."
BVD is spread within herds and to new herds through the presence of persistently infected (PI) animals. PIs can look relatively healthy and show no outward signs of infection but, as they were exposed to the virus as a foetus, have become virus carriers. If they are born alive, they will shed virus consistently throughout their lives so perpetuating the cycle of infection.
Alan said: "The foetal control delivered by Bovela gives absolute confidence that cows will not produce PIs. This, alongside the drastically improved convenience will undoubtedly make Bovela the natural choice for many farmers, both on beef and dairy farms."
According to Boehringer, around 60% of cattle in the EU test positive for exposure to the BVD virus and, although BVD type 1 is currently the most common form, outbreaks of BVD type 2, were confirmed in 2013 and 2014 in Belgium, Germany and The Netherlands. BVD type 2 is generally a more serious disease, with high levels of mortality and while the virus has been identified in UK, it has not yet been identified as the cause of serious outbreaks of disease in cattle.
Alan said: "Bovela is the first and only vaccine in UK which has been proven to protect cattle from BVD type 1 and 2. It has been in development for 17 years and, gained a marketing authorisation following assessment of an unprecedented quantity of data generated in both beef and dairy herds.
"Work has looked at the efficacy of Bovela in preventing the production of PI calves and against type 1 and 2 BVD as well as confirming its efficacy in young calves as young as three months of age as their natural maternal protection wears off. Trials also confirmed vaccine safety generally and during various stages of pregnancy. We do not believe that any other BVD vaccine has been tested as rigorously."